A detailed history of Rhumbline Advisers transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Rhumbline Advisers holds 288,287 shares of DGX stock, worth $39.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
288,287
Previous 293,190 1.67%
Holding current value
$39.5 Million
Previous $40.1 Million 1.52%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$137.09 - $137.09 $672,152 - $672,152
-4,903 Reduced 1.67%
288,287 $39.5 Million
Q2 2024

Aug 01, 2024

BUY
$125.91 - $144.34 $22,286 - $25,548
177 Added 0.06%
293,190 $40.1 Million
Q1 2024

May 09, 2024

BUY
$123.78 - $142.11 $1.23 Million - $1.42 Million
9,968 Added 3.52%
293,013 $39 Million
Q4 2023

Feb 08, 2024

SELL
$120.62 - $141.12 $815,873 - $954,535
-6,764 Reduced 2.33%
283,045 $39 Million
Q3 2023

Nov 09, 2023

SELL
$121.86 - $144.92 $417,492 - $496,495
-3,426 Reduced 1.17%
289,809 $35.3 Million
Q2 2023

Aug 08, 2023

SELL
$130.56 - $146.84 $44,259 - $49,778
-339 Reduced 0.12%
293,235 $41.2 Million
Q1 2023

May 11, 2023

SELL
$131.53 - $155.76 $1.64 Million - $1.94 Million
-12,443 Reduced 4.07%
293,574 $41.5 Million
Q4 2022

Feb 14, 2023

BUY
$123.31 - $157.26 $246,496 - $314,362
1,999 Added 0.66%
306,017 $47.9 Million
Q3 2022

Nov 10, 2022

BUY
$121.77 - $141.1 $335,719 - $389,012
2,757 Added 0.92%
304,018 $37.3 Million
Q2 2022

Aug 11, 2022

BUY
$127.07 - $145.39 $2.67 Million - $3.05 Million
20,987 Added 7.49%
301,261 $40.1 Million
Q1 2022

May 12, 2022

BUY
$129.09 - $164.35 $352,673 - $449,004
2,732 Added 0.98%
280,274 $38.4 Million
Q4 2021

Feb 10, 2022

BUY
$140.36 - $173.01 $270,333 - $333,217
1,926 Added 0.7%
277,542 $48 Million
Q3 2021

Nov 12, 2021

SELL
$132.95 - $158.0 $1.97 Million - $2.34 Million
-14,819 Reduced 5.1%
275,616 $40.1 Million
Q2 2021

Aug 05, 2021

BUY
$126.66 - $141.48 $21,278 - $23,768
168 Added 0.06%
290,435 $38.3 Million
Q1 2021

May 06, 2021

BUY
$114.63 - $133.34 $230,406 - $268,013
2,010 Added 0.7%
290,267 $37.3 Million
Q4 2020

Feb 10, 2021

SELL
$112.7 - $128.05 $2.41 Million - $2.74 Million
-21,407 Reduced 6.91%
288,257 $34.4 Million
Q3 2020

Nov 12, 2020

SELL
$107.05 - $130.01 $3.77 Million - $4.58 Million
-35,234 Reduced 10.22%
309,664 $35.5 Million
Q2 2020

Aug 13, 2020

SELL
$73.34 - $122.61 $4.67 Million - $7.8 Million
-63,618 Reduced 15.57%
344,898 $39.3 Million
Q1 2020

May 06, 2020

BUY
$75.14 - $115.68 $3.06 Million - $4.71 Million
40,695 Added 11.06%
408,516 $32.8 Million
Q4 2019

Feb 05, 2020

BUY
$100.29 - $107.99 $1.35 Million - $1.45 Million
13,437 Added 3.79%
367,821 $39.3 Million
Q3 2019

Oct 23, 2019

BUY
$97.85 - $107.42 $891,804 - $979,025
9,114 Added 2.64%
354,384 $37.9 Million
Q2 2019

Aug 14, 2019

BUY
$85.18 - $101.94 $3.75 Million - $4.49 Million
44,024 Added 14.61%
345,270 $35.2 Million
Q1 2019

May 01, 2019

SELL
$80.68 - $89.92 $1.38 Million - $1.54 Million
-17,160 Reduced 5.39%
301,246 $27.1 Million
Q4 2018

Jan 31, 2019

SELL
$79.75 - $108.38 $325,539 - $442,407
-4,082 Reduced 1.27%
318,406 $26.5 Million
Q3 2018

Nov 07, 2018

BUY
$105.42 - $114.99 $1.23 Million - $1.34 Million
11,639 Added 3.74%
322,488 $34.8 Million
Q2 2018

Aug 06, 2018

SELL
$97.35 - $113.14 $316,484 - $367,818
-3,251 Reduced 1.04%
310,849 $34.2 Million
Q1 2018

May 02, 2018

SELL
$96.42 - $107.88 $552,293 - $617,936
-5,728 Reduced 1.79%
314,100 $31.5 Million
Q4 2017

Feb 09, 2018

SELL
$90.86 - $100.24 $106,760 - $117,782
-1,175 Reduced 0.37%
319,828 $31.5 Million
Q3 2017

Nov 06, 2017

BUY
$91.96 - $108.35 $29.5 Million - $34.8 Million
321,003
321,003 $30.1 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.